Europe Pharmaceutical Grade Marijuana Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Pharmaceutical Grade Marijuana market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pharmaceutical Grade Marijuana Market Segmentations:

    By Player:

    • Teva Pharmaceutical

    • Sanofi-Aventis

    • Solvay Pharmaceuticals

    • GW Pharmaceuticals

    • Medical Marijuana Inc

    • Unimed Pharmaceuticals

    • Pharmos

    • Merck

    • Valeant Pharmaceuticals International

    By Type:

    • Sativex

    • Cesamet

    • Marinol

    • Dexanabinol

    • Cannabinor

    • Others

    By End-User:

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Hospitals

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Grade Marijuana Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Sativex from 2014 to 2026

    • 1.3.2 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Cesamet from 2014 to 2026

    • 1.3.3 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Marinol from 2014 to 2026

    • 1.3.4 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Dexanabinol from 2014 to 2026

    • 1.3.5 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Cannabinor from 2014 to 2026

    • 1.3.6 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • 1.4.2 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • 1.4.3 Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical Grade Marijuana Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical Grade Marijuana by Major Types

      • 3.4.1 Market Size and Growth Rate of Sativex

      • 3.4.2 Market Size and Growth Rate of Cesamet

      • 3.4.3 Market Size and Growth Rate of Marinol

      • 3.4.4 Market Size and Growth Rate of Dexanabinol

      • 3.4.5 Market Size and Growth Rate of Cannabinor

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Pharmaceutical Grade Marijuana Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical Grade Marijuana by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical Grade Marijuana for Research & Academic Laboratories

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical Grade Marijuana for Pharmaceutical & Biotechnology Companies

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical Grade Marijuana for Hospitals

    5 Market Analysis by Major Regions

    • 5.1 Europe Pharmaceutical Grade Marijuana Production Analysis by Top Regions

    • 5.2 Europe Pharmaceutical Grade Marijuana Consumption Analysis by Top Regions

    • 5.3 Europe Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pharmaceutical Grade Marijuana Market among Top Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical Grade Marijuana Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical Grade Marijuana Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pharmaceutical Grade Marijuana Landscape Analysis

    • 7.1 Germany Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 7.2 Germany Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    8. UK Pharmaceutical Grade Marijuana Landscape Analysis

    • 8.1 UK Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 8.2 UK Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    9. France Pharmaceutical Grade Marijuana Landscape Analysis

    • 9.1 France Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 9.2 France Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    10. Italy Pharmaceutical Grade Marijuana Landscape Analysis

    • 10.1 Italy Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 10.2 Italy Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    11. Spain Pharmaceutical Grade Marijuana Landscape Analysis

    • 11.1 Spain Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 11.2 Spain Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    12. Poland Pharmaceutical Grade Marijuana Landscape Analysis

    • 12.1 Poland Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 12.2 Poland Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    13. Russia Pharmaceutical Grade Marijuana Landscape Analysis

    • 13.1 Russia Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 13.2 Russia Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    14. Switzerland Pharmaceutical Grade Marijuana Landscape Analysis

    • 14.1 Switzerland Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 14.2 Switzerland Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    15. Turkey Pharmaceutical Grade Marijuana Landscape Analysis

    • 15.1 Turkey Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 15.2 Turkey Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 16.3.2 Finland Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 16.3.3 Norway Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 16.3.4 Sweden Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 16.3.6 Iceland Pharmaceutical Grade Marijuana Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 17.3.2 Netherlands Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pharmaceutical Grade Marijuana Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 18.3.2 Latvia Pharmaceutical Grade Marijuana Market Volume and Growth Rate

      • 18.3.3 Lithuania Pharmaceutical Grade Marijuana Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Teva Pharmaceutical

      • 19.1.1 Teva Pharmaceutical Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Sanofi-Aventis

      • 19.2.1 Sanofi-Aventis Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Solvay Pharmaceuticals

      • 19.3.1 Solvay Pharmaceuticals Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GW Pharmaceuticals

      • 19.4.1 GW Pharmaceuticals Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Medical Marijuana Inc

      • 19.5.1 Medical Marijuana Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Unimed Pharmaceuticals

      • 19.6.1 Unimed Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pharmos

      • 19.7.1 Pharmos Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Merck

      • 19.8.1 Merck Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Valeant Pharmaceuticals International

      • 19.9.1 Valeant Pharmaceuticals International Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 67 Figures and 127 Tables)

    • Figure Product Picture

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Sativex from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Cesamet from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Marinol from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Dexanabinol from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Cannabinor from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Research & Academic Laboratories from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2014 to 2026

    • Figure Europe Pharmaceutical Grade Marijuana Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Germany Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pharmaceutical Grade Marijuana Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Grade Marijuana Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical Grade Marijuana

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical Grade Marijuana by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Grade Marijuana by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Sativex

    • Figure Market Size and Growth Rate of Cesamet

    • Figure Market Size and Growth Rate of Marinol

    • Figure Market Size and Growth Rate of Dexanabinol

    • Figure Market Size and Growth Rate of Cannabinor

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical Grade Marijuana by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Grade Marijuana by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Hospitals

    • Table Europe Pharmaceutical Grade Marijuana Production by Major Regions

    • Table Europe Pharmaceutical Grade Marijuana Production Share by Major Regions

    • Figure Europe Pharmaceutical Grade Marijuana Production Share by Major Countries and Regions in 2014

    • Table Europe Pharmaceutical Grade Marijuana Consumption by Major Regions

    • Table Europe Pharmaceutical Grade Marijuana Consumption Share by Major Regions

    • Table Germany Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table UK Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table France Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Italy Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Spain Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Poland Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Russia Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Switzerland Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Turkey Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical Grade Marijuana Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Germany Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Germany Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Germany Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table UK Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table UK Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table France Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table France Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table France Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table France Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Italy Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Italy Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Spain Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Spain Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Poland Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Poland Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Russia Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Russia Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Grade Marijuana Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Grade Marijuana Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Grade Marijuana Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pharmaceutical Grade Marijuana Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Company Profile and Development Status of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Company Profile and Development Status of Solvay Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Solvay Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Solvay Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Solvay Pharmaceuticals

    • Table Product and Service Introduction of Solvay Pharmaceuticals

    • Table Company Profile and Development Status of GW Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of GW Pharmaceuticals

    • Figure Revenue and Market Share Analysis of GW Pharmaceuticals

    • Table Product and Service Introduction of GW Pharmaceuticals

    • Table Company Profile and Development Status of Medical Marijuana Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medical Marijuana Inc

    • Figure Sales and Growth Rate Analysis of Medical Marijuana Inc

    • Figure Revenue and Market Share Analysis of Medical Marijuana Inc

    • Table Product and Service Introduction of Medical Marijuana Inc

    • Table Company Profile and Development Status of Unimed Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unimed Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Unimed Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Unimed Pharmaceuticals

    • Table Product and Service Introduction of Unimed Pharmaceuticals

    • Table Company Profile and Development Status of Pharmos

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmos

    • Figure Sales and Growth Rate Analysis of Pharmos

    • Figure Revenue and Market Share Analysis of Pharmos

    • Table Product and Service Introduction of Pharmos

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.